Skip to main content

Clinical Trials Discriminate Against Older Persons with Diabetes


by: Ken Covinsky (@geri_doc)

Over half of persons with type 2 Diabetes are over the age of 65.  You would think that there would be tons of research studies that tell us how to best care for older persons with diabetes.  But the truth is that our understanding of geriatric diabetes is a vast wasteland.   Most major studies of diabetes have excluded older persons or have excluded older persons with co-existing disease or functional impairment.  Studies rarely tell us how treatment for diabetes impacts problems older persons care about such as functional impairment, cognitive function, falls, and incontinence.

But surely help must be on the way.  There has been a lot of attention recently to the issue of diabetes in older persons.  So, it must be the case that current studies of diabetes are starting to show they care about the real world patients with diabetes who are older and often have lots of other medical problems in addition to diabetes.

Well, think again.  A study in the Journal of the American Geriatrics Society shows that things are not getting better at all.  Current ongoing studies of diabetes are still characterized by pervasive and systematic discrimination against older patients.

The authors analyzed 440 protocols of ongoing studies of type 2 diabetes.  The findings are very discouraging:
  • 66% of studies excluded subjects using an arbitrary upper age limit.  Upper age limits are almost never justified.  Even when drugs are tested in mostly younger patients, they get heavily marketed and used by older patients
  • 77% of studies excluded subjects with comorbid conditions--diseases in addition to diabetes.  An acceptable justification for exclusions based on comorbidity was provided less than a 25% of the time.  The vast majority of patients with diabetes have comorbidity.  It is crucial we learn how comorbidity impacts the outcomes of treatment.  Exclusions based on comorbidity often makes the real world application of diabetes studies uninterpretable.
The authors note that responsibility for age discrimination rests with multiple players and notes responsibility of these players going forward:
  • Regulatory agencies such as the FDA must develop clear regulations that demand drugs will be tested in the patients that actually will use them before they are allowed to be widely used
  • Funders such as the NIH should stop turning a blind eye towards ageism in clinical research
  • Human subjects committees should avoid approving protocols that needlessly exclude older subjects
  • Older patients and those who care about them should insist that research that improves their care is a major societal need

Comments

Bob Fenton said…
Glad to see that people are finally realizing this. I have felt this discrimination since I was diagnosed. Fact is when I was considering changing doctors, the new doctor I was considering stated that I would need to come off insulin and go on oral medications. When I did not answer, he asked me to leave. I said gladly and said that he was obviously afraid of insulin and therefore an unfit doctor. Since then I have found out that he will not keep any patient needing insulin.
Hoyer Lift said…
I am glad someone is finally recognizing that the effects of geriatric diabetes on sufferers needs more attention. Hopefully as people live longer we will see more funding being allocated to research in the area.

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Survival from severe sepsis: The infection is cured but all is not well

Severe sepsis is a syndrome marked by a severe infection that results in the failure of at least one major organ system: For example, pneumonia complicated by kidney failure. It is the most common non-cardiac cause of critical illness and is associated with a high mortality rate.

But what happens to those who survive their hospitalization for severe sepsis? An important study published in JAMA from Iwashyna and colleagues provides answers and tells us all is not well. When the patient leaves the hospital, the infection may be cured, but the patient and family will need to contend with a host of major new functional and cognitive deficits.

Iwashyna examined disability and cognitive outcomes among 516 survivors of severe sepsis. These subjects were Medicare enrollees who were participants in the Health and Retirement Study. The average age of patients was 77 years.

When interviewed after discharge, most survivors were left with major new deficits in their ability to live independently. …